Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism. by Abbott, Geoffrey W & Goldstein, Steve AN
UC Irvine
UC Irvine Previously Published Works
Title
Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal 
promiscuous disruption of multiple currents and conservation of mechanism.
Permalink
https://escholarship.org/uc/item/99v7r735
Journal
FASEB journal : official publication of the Federation of American Societies for 
Experimental Biology, 16(3)
ISSN
0892-6638
Authors
Abbott, Geoffrey W
Goldstein, Steve AN
Publication Date
2002-03-01
DOI
10.1096/fj.01-0520hyp
License
https://creativecommons.org/licenses/by/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
 Disease-associated mutations in KCNE potassium channel subunits (MiRPs) 
reveal promiscuous disruption of multiple currents and conservation of 
mechanism 
GEOFFREY W. ABBOTT1 AND STEVE A. N. GOLDSTEIN2 
Departments of Pediatrics and Cellular and Molecular Physiology, Boyer Center for Molecular Medicine, Yale 
University School of Medicine, New Haven, Connecticut 06536 USA 
 
ABSTRACT  
KCNE genes encode single transmembrane-domain subunits, the MinK-related peptides (MiRPs), 
which assemble with pore-forming α subunits to establish the attributes of potassium channels in vivo. To 
investigate whether MinK, MiRP1, and MiRP2 operate similarly with their known native α subunit partners 
(KCNQ1, HERG, and Kv3.4, respectively) two conserved residues associated with human disease and 
influential in channel function were evaluated. As MiRPs assemble with a variety of α subunits in 
experimental cells and may do so in vivo, each peptide was also assessed with the other two a subunits. 
Inherited mutation of aspartate to asparagine (D → N) to yield D76N-MinK is linked to cardiac arrhythmia 
and deafness; the analogs D82N-MiRP1 and D90N-MiRP2 were studied. Mutation of arginine to histidine 
(R → H) to yield R83H-MiRP2 is associated with periodic paralysis; the analogs K69H-MinK and K75H-
MiRP1 were also studied. Macroscopic and single-channel currents showed that D → N mutations 
suppressed a subset of functions whereas R/K → H changes altered the activity of MinK, MiRP1, and 
MiRP2 with all three a subunits. The findings indicate that the KCNE peptides interact similarly with 
different a subunits and suggest a hypothesis: that clinical manifestations of inherited KCNE point mutations 
result from disruption of multiple native currents via promiscuous interactions.— Abbott, G. W., Goldstein, 
S. A. N. Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous 
disruption of multiple currents and conservation of mechanism. FASEB J. 16, 390 – 400 (2002) 
 
Key Words: MinK · MiRP1 · MiRP2 · KCNQ1 · HERG · Kv3.4 · periodic paralysis · cardiac arrhythmia 
 
Classical voltage-gated potassium channels contain four pore-forming  (α)  subunits  that  supply  domains 
that sense and respond to voltage and mediate ion permeation (1). In native cells, potassium channels 
incorporate additional subunits that modify attributes as varied as surface half-life, ion selectivity, gating 
kinetics, chemical and secondary messenger regulation, and pharmacology (2). Subunits encoded by KCNE 
genes are single transmembrane-domain peptides that assemble with α subunits to influence all these 
functional parameters (3). Thus, the KCNE1 product MinK (4) partners with the α subunit KCNQ1 to form 
the slowly activating cardiac current IKs found in heart and ear (5, 6). Similarly, the KCNE2 product MinK-
related peptide 1 (MiRP1) assembles with the α subunit HERG to generate a current resembling cardiac IKr 
(7) and the KCNE3 product MiRP2 combines with the Kv3.4 α subunit to form a subthreshold, A-type 
channel in skeletal muscle (8). Inherited mutations in MinK are associated with cardiac arrhythmia and 
deafness (9 – 12), those in MiRP1 with inherited and drug-induced cardiac arrhythmia (7, 13), and those in 
MiRP2 have been linked to periodic paralysis (8). 
These recognized MiRP/α subunit partnerships may not be unique. In experimental cells, MinK has 
been found to assemble not only with KCNQ1 (5, 6) but also with HERG (14); MiRP1 combines not only 
with HERG (7, 15), but with Kv4.2 (16, 17) and perhaps HCN1 (18); and MiRP2 associates not only with 
Kv3.4 (8) but with KCNQ1 and HERG (19, 20). Whereas such observations suggest that α subunits in native 
cells may rarely function alone (21), these varied partnerships have not yet been demonstrated in vivo. 
The idea that KCNE peptides can alter the function of more than one α subunit type suggests they 
might operate in different complexes in similar fashion, presumably via common subunit-subunit  
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interactions. To explore this notion, we studied two residues essential to MinK and MiRP2 function and 
strongly conserved in the five known MiRPs: D76N-MinK was recognized by its association with inherited 
arrhythmia and deafness and alters function of channels formed with KCNQ1; an equivalent aspartate (D) is 
present in all but MiRP3 (2, 9, 12, 22). R83H-MiRP2 was identified by its sway over channels formed with 
Kv3.4 and association with periodic paralysis; an homologous arginine (R) or lysine (K) is found in all five 
MiRPs (2, 3, 8). Here, despite changes at these conserved sites in MinK, MiRP1, and MiRP2, each peptide 
retained the capacity to form functional complexes with its α subunit partners (KCNQ1, HERG, and Kv3.4); 
conversely, D → N changes eliminated MiRP-mediated current up-regulation (but not down-regulation) and 
R/K → H mutations suppressed effects on current activation, deactivation, and magnitude, suggesting this 
residue may have a key role in activity. The findings demonstrate that many MiRP/α subunit operations do 
proceed by shared mechanisms. The results suggest a hypothesis for how a single KCNE point mutation 
might cause disease—through effects on more than one α subunit channel type in vivo. 
 
 
MATERIALS AND METHODS 
 
Heterologous expression 
 
Mutations were produced in wild-type human KCNE2 and KCNE3 in pGA1 (7) or wild-type human 
KCNE1 (Ser38 variant) in pRAT (23) by pfu-based mutagenesis (Quick-Change Kit; Stratagene, La Jolla, 
CA), followed by insertion of mutant gene fragments into translationally silent restriction sites and 
confirmed by DNA sequencing. For studies in oocytes, cRNA was produced as before (7). Chinese hamster 
ovary (CHO) cells were treated with Superfect (Qiagen, Chatsworth, CA) and plasmids carrying the genes 
for MIRP2, Kv3.4, and green fluorescent protein were expressed in pCI neo-based vectors (Promega, 
Madison, WI), as before (8). 
 
Electrophysiology 
 
CHO cells 
 
Kv3.4 and MiRP2-Kv3.4 channels were assessed using CHO cells by whole-cell or patch clamp 1–3 
days after transfection. Recording was with an Axopatch 200A Amplifier (Axon Instruments, Foster City, 
CA), an IBM computer, and CLAMPEX software (Axon). Data analysis was performed using CLAMPFIT, 
FETCHAN, PSTAT (Axon), and TAC 
software (Instrutech, Great Neck, NY). 
 
Oocytes 
 
HERG, KCNQ1, or Kv3.4 channels with and without MinK, MiRP1, or MiRP2 were assessed using 
Xenopus laevis oocytes and two-electrode voltage clamp (TEVC), as before (7). Resting membrane potential 
(RMP) of oocytes was assessed at steady state in current clamp. All experiments were performed at room 
temperature. Oocytes were used for most subunit partnerships. MiRP2/Kv3.4 channels were usually studied 
in CHO cells, as regulatory influences maintain stable current levels over the course of measurements (not 
shown). That MiRP2/Kv3.4 complexes do assemble in oocytes is shown by altered affinity of BDS-II here 
and earlier (8). Such cell-specific effects of KCNE peptides on current density and pharmacology are not 
without precedent; see refs 14, 24 for differential effects of D76N-minK on HERG and (7)  for altered E-
4031 blockade, respectively. For BDS-II blockade, CHO cell recordings were performed using outside-out 
patches, oocyte recordings using whole-cell TEVC; BDS-II was applied via a bath in both cases. 
 
Protocols 
  
Holding voltage was -80 mV unless stated otherwise. 1: Peak patch current; 3 s pulse from -100 to 90 
mV in 10 mV steps with a 10 s interpulse interval. 2: Single voltage/drug inhibition; repetitive 3 s pulses to a 
single voltage as indicated with a 5 s interpulse interval. 3: Steady state; holding at -40 mV for 5–20 min 
with no interpulse interval. 4: Peak whole-cell current;  3  s  pulse  from  -120  to  60  mV  in  20  mV  steps, 
followed by a 1.5 s tail pulse to -30 mV, with a 10 s interpulse interval. 5: Peak whole-cell current (MinK); 5 
s pulse from -80 to 60 mV in 20 mV steps with a 10 s interpulse interval. 6: Steady-state activation; 3 s 
prepulse from -80 to 60 mV in 20 mV steps, followed by a 3 s pulse to -30 mV, with a 10 s interpulse 
interval. 7: Peak tail current/deactivation kinetics; 3 s prepulse to 40 mV, followed by a 3 s pulse from -120 
to 60 mV in 20 mV steps with a 10 s interpulse interval. 
 
Ionic conditions 
 
Pipette solution for CHO cells in on-cell mode was (in mM): 100 KCl, 0.7 MgCl2, 1 CaCl2, 10 
HEPES pH 7.4. CHO cell bath solution was as in the pipette. Bath solution for oocytes was (in mM) 4 KCl, 
96 NaCl, 0.7 MgCl2, 1 CaCl2, 10 HEPES pH 7.4; for RMP measurements, KCl was varied from 0.01 to 100 
mM, with NaCl being substituted to keep the total monovalent ion concentration at 100 mM. 
 
RESULTS 
 
A conserved KCNE site influential in both MinK/KCNQ1 and MiRP2/Kv3.4 channels 
 
MinK assembles with KCNQ1 to slow channel activation, alter the voltage dependence of gating, 
and increase unitary conductance, thereby producing the attributes of native IKs channels (5, 6). Aspartate 
(D) to asparagine (N) mutation to yield D76N-MinK is associated with inherited long QT syndrome, sudden 
death, and deafness (9 –11). Compared with wild-type MinK/ KCNQ1 channels, the mutant reduces current 
density due to a shift of voltage-dependent activation to more positive potentials and a fourfold reduction in 
unitary conductance (9, 12). Sequence alignment of MinK, MiRP1, and MiRP2 indicates that D76-MinK is a 
conserved residue (Fig. 1); a homologous D is also present in MiRP4 but not MiRP3 (3). To assess whether 
this site was significant to MiRP2 function, D90N-MiRP2 was produced and studied with its skeletal muscle 
partner Kv3.4. 
Wild-type MiRP2 shifts the voltage dependence of channels formed with Kv3.4 to more negative 
potentials (change ~ -45 mV) to create a channel that activates at subthreshold levels and has an increased 
unitary conductance (8). Compared with wild-type MiRP2/ Kv3.4 channels, expression of D90N-MiRP2 
reduced outward current density 3- to 4-fold (345±84 and 90±12 pA at 90 mV, respectively, n=9 –11 
patches) and diminished  inward  currents  18-fold  (-91±35  and -4.7±1.2  pA,  respectively,  at  -50  mV)  
using  CHO cells, on-cell patches, and ~ symmetrical potassium across the membrane (Fig. 2A, B). The 
mutation produced a +35 mV change in the midpoint activation potential (V1/2) from -38 ± 1.0 to 2.8 ± 3.7 
mV (Fig. 2C), similar to the value of Kv3.4 channels without MiRP2 (8). 
 
 
 
 
 
 
 
  
Figure 1. Partial sequence and predicted topology of KCNE-encoded, MinK-related peptides (MiRPs). Predicted topology 
(left) and partial sequences (right) of human MinK, MiRP1, and MiRP2 indicating extracellular (out) N and intracellular (in) 
C termini; alignment with numbering for MinK shows part of the predicted transmembrane (thick line) and membrane-
following region (thin line) with sites studied boxed in black: K69H (MinK); K75H (MiRP1); R83H (MiRP2) [open 
square]; D76N (MinK); D82N (MiRP1); D90N (MiRP2) [gray square]. 
  
Whenever KCNE mutation yielded attributes like those for channels formed by α subunits alone, we 
sought evidence to confirm that the altered peptides were assembled into the channel complex. Two 
observations with macroscopic currents indicated that channels did contain D90N-MiRP2 subunits. First, the 
slope of the conductance-voltage relationship with D90N-MiRP2 was similar to that for wild-type MiRP2 
(13±2.0 and 14±1.4, respectively) rather than that for homomeric Kv3.4 channels (22.5±0.6) (Fig. 2C). 
Second, channels with D90N-MiRP2 were blocked by the peptide toxin BDS-II like those containing wild-
type MiRP2 (Ki=633±110 and 688±166 nM at+30 mV, respectively, n=4 –5 cells), and significantly 
different from channels formed with Kv3.4 subunits alone, which showed ~sixfold greater sensitivity to the 
toxin (99.5±32 nM) (Fig. 2D)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. D90N-MiRP2/Kv3.4 channels show altered voltage dependence and reduced potassium flux. Studies of wild-type 
MiRP2/ Kv3.4 (black squares), D90N-MiRP2/Kv3.4 (gray squares), and Kv3.4 (dashed line) performed in CHO cells in on-
cell patches with 100 mM potassium solution in bath and pipette using protocol 1. Sampled at 5 kHz, filtered at 1 kHz or 
500 Hz. A) Representative current families in patches with high channel density; holding voltage -80 mV, steps from -100 
to 90 mV (inset, protocol 1); scale bars 20 pA and 100 ms; zero current level (dashed line). B) Peak current-voltage 
relationship for recordings as in panel A. Mean ± se, n = 9 –11 patches; inset, normalized current-voltage relationship. C) 
Normalized conductance-voltage relationship for panel B. Curves fit to a function of the form: 1/{1+exp[(V1/2- V)/Vs]}, 
where V1/2 is the half-maximal voltage of activation and Vs the slope factor; values in text.; error bars indicate se. Dashed 
line shows results for homomeric Kv3.4 channels as reported (8). D) Blockade by BDS-II. Dose-response curves using 
Xenopus oocytes and protocol 2. Various levels of BDS-II applied in the bath with 4 mM potassium solution. Bars indicate 
equilibrium inhibition constant calculated from fits to the function: y = [A1-A2/{1+(x/xo)p}]+A2, where x is added toxin, xo 
the inhibition constant, and p the Hill coefficient. Mean ± se for 4 –5 oocytes. Kv3.4 (open); wild-type MiRP2/Kv3.4 
(black); D90N-MiRP2/Kv3.4 (gray). 
 
 
At the single-channel level, the effects of D76N-MinK on KCNQ1 and D90N-MiRP2 on Kv3.4 were 
also similar (Fig. 3). 1) D90N-MiRP2 produced a shift in activation voltage such that openings were rare and 
short-lived at voltages negative to -20 mV (Fig. 3A). 2) Mean unitary current amplitude was lowered by 
D90N-MiRP2 (Fig. 3B, C). Thus, wild-type MiRP2/Kv3.4 single channels showed two current amplitude 
levels (Fig. 3B, 1.5±0.1 and 2.2±0.1 pA at 60 mV) whereas D90N-MiRP2/Kv3.4 channels showed a single 
level similar in magnitude to the lower wild-type current level (Fig. 3B, 1.6±0.1 pA at 60 mV), similar to 
channels with Kv3.4 subunits alone (8). 3) Analysis of channel gating kinetics revealed that steady-state 
open probability (Po) at -40 mV for channels with D90N-MiRP2 was ~10-fold lower than for wild-type 
 MiRP2/Kv3.4 channels, Po = 0.0040 ± 0.0004 and 0.04 ± 0.10, respectively, n = 3–5 patches (Fig. 3D, E, 
upper). Both wild-type and D90N-MiRP2 channels showed two open state dwell times (Fig. 3E lower); 
D90N mutation led to shortening of both dwell times and preferential occupancy of the shorter open state. 
Thus, dwell-time analysis for D90N-MiRP2/Kv3.4 channels suggested open dwell times with time constants 
(τ) of 0.7 ± 0.3 and 3.9 ± 0.3 ms (weights of 0.37±0.1 and 0.63±0.1, respectively) vs. wild-type 
MiRP2/Kv3.4 channels (τ = 1.80±0.03 and 21.0±0.1 ms, weights of 0.49±0.03 and 0.51±0.04, Fig. 3E, 
lower). Although dwell-time statistics for D90N-MiRP2/Kv3.4 channels should be treated with caution due 
to infrequent openings at this voltage, incorporation of the mutant into the complex was readily appreciated 
because single Kv3.4 channels demonstrate short-lived dwell times best fit to just a single exponential, as 
reported (τ = 2.60±0.06 ms) (8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. D90N-MiRP2/Kv3.4 channels show lower unitary current and open probability. Studies of single wild-type 
MiRP2/Kv3.4 or D90N-MiRP2/ Kv3.4 channels expressed in CHO cells with on-cell-attached patches and 100 mM 
potassium solution in bath and pipette. Sampled at 5 kHz, filtered at 1 kHz for analysis, and 500 Hz for presentation. A) 
Activation (arrow) of ~5 D90N-MiRP2/Kv3.4 channels by steps from a holding voltage of -80 mV according to protocol 1. 
Scale bars, 2 pA and 500 ms. B) Upper panel: single-channel openings at 60 mV for wild-type MiRP2/Kv3.4 (left) or 
D90N-MiRP2/ Kv3.4 (right). Scale bars represent 1 pA and 50 ms. Dashed lines at open state levels: o, open; c, closed. 
Lower panel: all-points histograms for openings at 60 mV for wild-type MiRP2/Kv3.4 (left) or D90N-MiRP2/Kv3.4 (right) 
channels; mean current levels in text. C) Unitary current-voltage relationship calculated from all-points histograms as in 
panel B for wild-type MiRP2/Kv3.4 (thin line, ref 8) and D90N-MiRP2/Kv3.4 (gray squares), mean ± SE for 3–9 patches per 
point. D) Single-channel steady-state currents; scale bars 1 pA and 500 ms (protocol 3). Representative traces (6 s per line) 
are continuous and taken from 5–10 min records. Top: wild-type MiRP2/Kv3.4; bottom: D90N-MiRP2/Kv3.4. E) Upper 
panel: all-points histograms from steady-state wild-type MiRP2/Kv3.4 (dashed) and D90N-MiRP2/Kv3.4 (solid line) single-
channels held at -40 mV for 5–10 min and indicative of Po. Lower panel: dwell-time histogram at -40 mV from single 
D90N-MiRP2/Kv3.4 channels held at steady state for 5–10 min; fit to a double exponential function (solid line) using 
Marquardt least-squares (PSTAT). A double exponential function dwell-time fit for single wild-type MiRP2/Kv3.4 channels 
is shown for comparison (dashed line). Wild-type fits as reported (8); τ values in text. 
 
 
KCNQ1 is similarly affected by D76N-MinK and D90N-MiRP2 
 
Whereas MinK is the ‘classical’ partner for KCNQ1 (5, 6), expression of MiRP2 with KCNQ1 in 
experimental cells produces a potassium-selective, voltage-insensitive (leak-type) current (Fig. 4A), as 
 others have shown (20). Here we report that D90N-MiRP2 acts like D76N-MinK to alter the voltage 
dependence and decrease macroscopic current passed by KCNQ1-containing channels. Compared with wild-
type MiRP2, D90N-MiRP2 decreased macroscopic current density ~four-fold: mean current at 40 mV was 
1.9 ± 0.2 µA for channels with D90N-MiRP2 vs. 7.3 ± 0.4 µA for wild-type MiRP2/KCNQ1 channels. 
Homomeric channels with KCNQ1 alone passed 4.6 ± 0.4 µA under the same conditions (Fig. 4B, n = 18-24 
cells). Furthermore, D90N-MiRP2 restored time and voltage dependence to MiRP2/KCNQ1 currents. Thus, 
wild-type MiRP2/ KCNQ1 channels displayed a linear current-voltage relationship  from  -120  to  +60  mV  
whereas  D90N-MiRP2/KCNQ1 channels were well fitted to a Boltzmann function with a V1/2 of -9 ± 3 mV 
and slope of 24 ± 2, more similar to KCNQ1 channels (V1/2 = 1 ± 3 mV, slope = 23 ± 3) (Fig. 4B). 
The D90N-MiRP2 subunit also acted to decrease the influence of MiRP2/KCNQ1 channels on RMP. 
The RMP of oocytes expressing only wild-type MiRP2 was not significantly different from control cells 
whereas expression of MiRP2 and KCNQ1 produced a shift of -72  ±  3  mV,  D90N-MiRP2  and  KCNQ1  
a  shift  of -36 ± 7 mV, and KCNQ1 alone a -22 ± 2 mV change when evaluated with a low potassium bath 
solution (Fig. 4C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. D90N-MiRP2/KCNQ1 channels show reduced current density and recovery of voltage and time dependence. 
Channels with KCNQ1 (triangle), wild-type MiRP2/ KCNQ1 (filled squares), or D90N-MiRP2/ KCNQ1 (gray squares) in 
oocytes by two-electrode voltage clamp. A) Representative currents recorded with protocol 1 in oocytes and 4 mM 
potassium solution in the bath. Dashed line indicates zero current level; scale bars, 2 µA and 1 s. B) Current-voltage 
relationships for cells as in panel A; mean ± se for 18 –24 oocytes. Wild-type MiRP2/ Kv3.4 fit with a straight line; Kv3.4 
and D90N-MiRP2/Kv3.4 fit to a function of the form: 1/{1+exp[(V1/2-V)/Vs]}, where V1/2 is the half-maximal voltage of 
activation and Vs the slope factor. C) Change in mean resting membrane potential from control (RMPExpt-Cntl) for various 
concentrations of bath potassium. Oocytes with wild-type MiRP2 alone (open circle) did not differ from control. Values are 
in text. Mean ± SE for 5–10 oocytes. 
 
 
R83H-MiRP2 affects KCNQ1 and Kv3.4 similarly 
 
MiRP2 assembles with Kv3.4 to form a potassium channel active at subthreshold potentials that 
influences skeletal muscle cell RMP; the missense mutant R83H-MiRP2 is associated with an inherited 
periodic paralysis; compared with wild-type MiRP2, the mutant reduces currents and causes skeletal muscle 
cell depolarization (8). Three effects of the mutation on Kv3.4-containing channels are described here. 
1) The R83H variant altered voltage dependence of gating, producing a shift in the V1/2 for activation 
 of ~ +30 mV to -9.2 ± 2.1 mV (Fig. 5A, B); this remains ~ 10 mV more negative than the V1/2 of homomeric 
Kv3.4 channels (Fig. 2C). The slope conductance for R83H-MiRP2/Kv3.4 currents was 19 ± 2.2 mV (n=9 
patches), intermediate between that of D90N-MiRP2/ Kv3.4 and wild-type MiRP2/Kv3.4 channels (Fig. 
5B). 2) At the single-channel level, R83H-MiRP2/Kv3.4 currents were of slightly smaller amplitude than 
wild-type and displayed fewer openings at negative potentials (Fig. 5C, D). Thus, R83H-MiRP2/Kv3.4 
channels exhibited two open states (like wild-type), but the larger current measured just 1.8 ± 0.2 pA at 60 
mV (n=5) vs. 2.2 ± 0.1 pA for wild-type (Fig. 3B). 3) Steady-state open probability (Po) at -40 mV for 
channels with R83H-MiRP2 was 0.006 ± 0.002 (n=11 patches), ~10-fold lower than for wild-type 
MiRP2/Kv3.4 channels but 12-fold more active than homomeric Kv3.4 channels (Fig. 5E, F). Although 
channels with R83H-MiRP2 showed two open state dwell times like wild-type (Fig. 5F, lower), the mutation 
shortened both dwell times and favored occupancy of the shorter opening. Thus, R83H-MiRP2/Kv3.4 had 
open state time constants (τ) of 0.48 ± 0.2 and 9.8 ± 0.2 ms (weights of 0.78 ± 0.2 and 0.22 ± 0.03, 
respectively), values intermediate between those of D90N-MiRP2/Kv3.4 and wild-type MiRP2/ Kv3.4 
channels (Fig. 3E). We previously showed that the effects of the R83H mutation were not due to altered 
subunit assembly as R83H-MiRP2/Kv3.4 channels in excised CHO cell patches were blocked by BDS-II 
(like those with wild-type MiRP2) and ~ 20-fold less effectively than homomeric Kv3.4 channels (8). 
The effects of R83H-MiRP2 on KCNQ1 were similar to those of D90N-MiRP2 although less potent 
(Fig. 6). Like channels with wild-type MiRP2, R83H-MiRP2/ KCNQ1 exhibited a largely linear current-
voltage relationship; however, the mutation restored some time and voltage dependence to channel 
activation and decreased macroscopic currents (Fig. 6A, B). Flux was decreased ~twofold from 7.3 ± 0.4 µA 
for channels with wild-type MiRP2 to 4.3 ± 0.3 µA for channels with R83H-MiRP2 (Fig. 6B), similar to 
what is seen with homomeric KCNQ1 channels (Fig. 4B). As a result, the RMP of R83H-MiRP2/KCNQ1-
expressing cells was shifted by +15 ± 7 mV in comparison to those with wild-type MiRP2/KCNQ1 channels 
(Fig. 6B, inset). Confirmation that R83H-MiRP2 subunits remained competent to assemble with KCNQ1 
was afforded by clotrimazole, which blocked homomeric KCNQ1 channels less effectively (Ki = 419±22 
µM) than either those with wild-type or R83H-MiRP2 (Ki= 217±20 and 177±18 µM, respectively) (Fig. 6C). 
 
K69H-MinK also alters KCNQ1 function 
 
K69H-MinK subunits were studied with KCNQ1 to assess whether this site, analogous to R83H-
MiRP2, was significant to function. Like wild-type MinK, K69H-MinK led to slow activation of KCNQ1-
containing channels with depolarization (Fig. 7A). Conversely, K69H-MinK shifted the half-maximal 
activation to 50 ± 0.1 mV (without a significant change in slope) from 30 ± 0.8 mV as measured for wild-
type MinK/KCNQ1 channels (Fig. 7B). The mean current passed by K69H-MinK/KCNQ1 channels was 
~twofold lower than those with wild-type MinK at both 40 mV (2.7±0.2 vs. 5.4±0.1 µA at, n=14) and -80 
mV (265±22 nA vs. 671±60 nA) (Fig. 7C). K69H-MinK/KCNQ1 channels showed faster deactivation 
kinetics with a mean time constant (τ) for deactivation of 277 ± 16 ms (-80 mV) vs. 827 ± 75 ms for wild-
type complexes (Fig. 7D, E). Effects on KCNQ1 inactivation (25) were not evaluated. 
 
R/K → H suppresses all KCNE effects on HERG whereas D → N impedes only up-regulation 
 
MiRP1 assembles with HERG to pass currents with the attributes of cardiac IKr channels, and 
inherited variants of MiRP1 are associated with congenital long QT syndrome and drug-induced torsades de 
pointes (7, 13). MiRP1 mutations associated with disease reduce currents passed through channels formed 
with HERG by decreasing unitary conductance, shifting the V1/2 of activation, speeding deactivation, and/or 
increasing sensitivity to drug blockade. HERG was studied here with K75H-MiRP1 and D82N-MiRP1, 
changes analogous to those associated with disease when carried in MiRP2 and MinK; then R83H-MiRP2 
and D90N-MiRP2 were evaluated. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. R83H-MiRP2/Kv3.4 complexes show altered voltage dependence, lower unitary current, and diminished open 
probability. Studies of R83H-MiRP2/Kv3.4 (filled circles) vs. wild-type MiRP2/ Kv3.4 (dashed line) and Kv3.4 (dotted 
line) performed in CHO cells in on-cell patches with 100 mM potassium solution in bath and pipette using protocol 1. 
Sampled 5 kHz, filtered at 1 kHz or 500 Hz. A) Representative R83H-MiRP2/Kv3.4 current family from a high channel 
density patch with holding voltage -80 mV, steps from -100 to 90 mV (inset, protocol 1); scale bars 50 pA and 500 ms; zero 
current level (dashed line). B) Normalized mean conductance-voltage relationship for patches as in panel A (n=9 –16 
patches). Curves fit to a function of the form: 1/{1+exp[(V1/2-V)/ Vs]}, where V1/2 is the half-maximal voltage of activation 
and Vs the slope factor; values in text.; error bars indicate se. Dashed line shows results for wild-type MiRP2/Kv3.4 
channels (Fig. 2); dotted line shows results for homomeric Kv3.4 channels as reported (8). C) Activation of ~5 R83H-
MiRP2/Kv3.4 channels by steps from a holding voltage of -80 mV according to protocol 1. Scale bars, 2 pA and 1 s. D) 
Unitary current-voltage relationship calculated from all-points histograms constructed with > 2 x 105 events (>500 
transitions) per patch for wild-type MiRP2/Kv3.4 (dashed line, ref 8) and R83H-MiRP2/Kv3.4 (solid line, filled circles); 
mean ± se for 4 –5 patches per point. E) Representative single-channel R83H-MiRP2/Kv3.4 steady-state currents at -40 mV; 
scale bars 1 pA and 500 ms (protocol 3). Traces (6 s per line) are continuous and taken from 5–10 min records. F) Upper 
panel: representative all-points histograms from steady-state wild-type MiRP2/Kv3.4 (dashed) and R83H-MiRP2/Kv3.4 
(solid line) single-channels held at -40 mV for 5–10 min and indicative of Po. Lower panel: representative dwell-time 
histogram at -40 mV from a single R83H-MiRP2/Kv3.4 channel held at steady state for 5–10 min; fit to a double 
exponential function (solid line) using Marquardt least-squares (PSTAT). A double exponential function dwell-time fit for 
single wild-type MiRP2/Kv3.4 channels is shown for comparison (dashed line). Wild-type fits as reported (8); τ values in 
text. 
 
 
 The K75H mutation decreased the down-regulatory effects of MiRP1 on HERG. K75H-
MiRP1/HERG complexes showed a mean tail current density of 2.5 ± 0.2 µA at -30 mV similar to HERG 
channels (3.1±0.1 µA) rather than wild-type MiRP1/HERG channels (0.76±0.1 µA, n=16 –20 cells) (Fig. 
8A, left; B). Similarly, current deactivation with K75H-MiRP1 was like that of homomeric HERG channels 
(τ=838±85 and 970±72 ms at -100 mV, respectively) rather than wild-type MiRP1/HERG complexes 
(τ=221±8 ms) (Fig. 8A: right, C). Conversely, the D82N change did not interfere with the capacity of 
MiRP1 to reduce HERG currents or speed deactivation rates. D82N-MiRP1 channels showed a mean tail 
current density of 0.84 ± 0.1 µA (Fig. 8A, B) and a mean deactivation rate at -100 mV of 196 ± 7 ms (Fig. 
8C), not significantly different from channels with wild-type MiRP1. 
 
 
Figure 6. R83H-MiRP2/KCNQ1 complexes also show reduced current density and recovery of voltage and time 
dependence. Properties of channels formed with KCNQ1 (triangle), MiRP2/KCNQ1 (filled square), or R83H-
MiRP2/KCNQ1 (open square) in oocytes studied by two-electrode voltage clamp. A) Representative current traces using 
protocol 4 in 4 mM potassium bath solution. Dashed line indicates zero current level; scale bars represent 2 mA and 1 s. B) 
Current-voltage relationships for cells as in panel A; mean ± SE for 16 –22 oocytes. Wild-type MiRP2/Kv3.4 fit with a 
straight line; R83H-MiRP2/Kv3.4 fit to a function of the form: 1/{1+exp[(V1/2-V)/Vs]}, where V1/2 is the half-maximal 
voltage of activation and Vs the slope factor. Dashed line with no symbols indicates KCNQ1 alone values for comparison. 
Inset: RMP studied as in panel C of Fig. 4; mean ± SE for 5– 8 oocytes. C) Clotrimazole dose-response for Kv3.4, wild-type 
MiRP2/Kv3.4 or R83H-MiRP2/Kv3.4 fit to the function: y = [A1-A2/{1+(x/xo)p}] + A2, where x is added drug, xo the 
inhibition constant, and p the Hill coefficient. Inhibition was assessed at 0 mV with various levels of drug in the bath and a 
repetitive pulse protocol (protocol 2); mean ± SE for 3–5 oocytes. 
 MiRP2 suppresses HERG currents in experimental cells by ~60% (Fig. 9A) as reported by Schroeder 
and colleagues (20). R83H-MiRP2 suppressed HERG much less efficiently (~20%): mean tail currents at -
30 mV were 770 ± 140 nA for R83H-MiRP2/HERG channels, 320 ± 84 nA for channels with wild-type 
MiRP2, and 960 ± 54 nA for homomeric HERG channels (Fig. 9B). Just as D82N-MiRP1 influenced HERG 
like wild-type MiRP1 (Fig. 8), so D90N-MiRP2 suppressed HERG currents as efficiently as wild-type 
MiRP2: cells expressing D90N-MiRP2 and HERG showed mean tail currents of  330  ±  62  nA  at  -30  
mV,  an  ~60%  suppression current (Fig. 9B). Conversely, wild-type MinK has been shown to augment 
HERG currents by increasing the active fraction of channels in the membrane whereas D77N rat MinK 
(equivalent to D76N-human MinK) suppressed this up-regulatory effect despite its continued capacity to 
assemble with HERG (14, 24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. K69H-MinK/KCNQ1 complexes show altered voltage dependence speeded deactivation and reduced potassium 
flux. Channels formed with wild-type MinK/ KCNQ1 (filled square) or K69H-MinK/KCNQ1 (open square) in oocytes 
studied by two-electrode voltage clamp. A) Representative current traces with protocol 5 (in-set) in 4 mM bath potassium 
solution. Scale bars, 1 µA and 1 s. B) Current-voltage relationships for cells as in panel A; mean ± SE for 14 oocytes. Curves 
fit to a function of the form: 1/{1+exp[(V1/2-V)/ Vs]}, where V1/2 is the half-maximal voltage of activation and Vs the slope 
factor. Inset: normalized conductance-voltage relationship. C) Tail current-voltage relationships for panel B. D) Normalized 
tail currents at -80 mV with a prepulse to 40 mV for wild-type MinK/ KCNQ1   (boldface)   or  K69H-MinK/KCNQ1 (thin). 
Scale bar represents 200 ms. E) Deactivation rates from tail currents as in panel D; fit to a single exponential; mean ± SE for 
7 oocytes in each group. 
 
DISCUSSION 
 
Common effects of conserved sites in different MiRP/a subunit complexes 
 
Two conserved residues have been studied to assess how KCNE peptides (MiRPs) alter α subunit function 
and to determine whether these sites influence different α subunits similarly. The sites were chosen because 
their inheritance in mutant form has been associated with disease and altered channel function. Mutation of 
these residues in MinK, MiRP1, or MiRP2 was found to have similar effects in channels formed with 
KCNQ1 or Kv3.4. Each wild-type MiRP acted with these α subunits to increase potassium current, and both 
D→ N changes (MinK-76, MiRP1– 82, and MiRP2–90) and R/K→ H changes (MinK-69, MiRP1–75, and 
MiRP2– 83) disrupted this capacity to increase flux. Like arrhythmia-associated D76N-MinK with KCNQ1 
(12), D90N-MiRP2 shifted activation of Kv3.4 channels to more depolarized potentials, diminished steady-
state open probability, lowered unitary conductance, and altered the voltage dependence KCNQ1 channels to 
 diminish current density. Like periodic paralysis-associated R83H-MiRP2 with Kv3.4 (8), R83H-MiRP2 and 
K69H-MinK decreased current through KCNQ1 channels due to a shift in activation to more depolarized 
potentials. 
 
 
Figure 8. K75H, but not D82N, alters function of MiRP1/HERG complexes. Channels formed with HERG (triangle), wild-
type MiRP1/HERG (filled square), K75H-MiRP1/HERG (open square), or D82N-MiRP1/HERG (gray square) in oocytes 
studied by two-electrode voltage clamp. A) Left panels. Currents with a varied prepulse voltage and a -30 mV tail (protocol 
6, inset). Right panels: 40 mV prepulse with varied tail test voltage (protocol 7, inset). Bath solution was 4 mM potassium 
solution. Scale bars represent 1 µA and1 s. B) Current-voltage relationships for cells as in panel A (left) measured at arrow; 
mean ± SE for 16 –20 oocytes. Curves fit to a function of the form: 1/{1+exp[(V1/2-V)/Vs]}, where V1/2 is the half-maximal 
voltage of activation and Vs the slope factor. C) Deactivation  rates  at  -100  mV  as  in panel A (right); fit to a single 
exponential; mean ± SE for 7– 8 oocytes; HERG (hatched); wild-type MiRP1/HERG (black); K75H-MiRP1/HERG (open); 
D82N-MiRP1/HERG (gray). 
 
 
HERG α subunits are stimulated by assembly with MinK and suppressed by MiRP1 and MiRP2 (14, 
20) and the two conserved residues exhibited differential effects on these regulatory events. Whereas 
stimulation of HERG was impeded by D77N mutation in rat minK (14), D82N-MiRP1 and D90N-MiRP2 
suppressed activity like wild-type subunits. Conversely, K75H-MiRP1 and R83H-MiRP2 suppressed HERG 
less effectively than did wild-type. 
Thus, R/K→ H mutation disrupted the ability of all three KCNE peptides to alter α subunit function whether 
the wild-type effect was to increase or suppress current. This residue appears to be important for normal 
MiRP function. Whereas D→ N mutation disabled the ability of the MinK to increase potassium flux, it did 
not alter MiRP1 or MiRP2 suppression of HERG, suggesting either a more specific role for this residue or 
that the unique attributes of HERG yield this behavior. These effects of KCNE peptide mutations indicate 
their operation by common mechanisms and shared structures. 
Sites of contact between MiRPs and α subunits remain to be identified. Studies using mutagenesis, 
modification, pharmacology, electrophysiology, and antibody binding have revealed that KCNE peptides are 
type I transmembrane proteins that appear to cross the membrane in proximity to the channel pore (2, 7, 8, 
22, 26). The effects of disease-associated mutations support a general correlation of function and domain: 
mutations in the extracellular region of MiRP1 alter voltage-dependent activation and drug blockade (T8A 
and Q9E) (7, 13); mutations in the transmembrane and membrane-following segments influence gating 
kinetics and ion conduction (7–9, 12). Indeed, transplantation of residues 57–59 from the transmembrane 
segment of MinK to the equivalent sites in MiRP2 was sufficient to convert MiRP2/KCNQ1 channels from 
leak-type conductances to slowly activating MinK/ KCNQ1-like channels (19). The two sites studied here 
 reside in the membrane-following region, and their potent influence on gating and pore function suggests an 
interaction with α subunit S4, S5, and/or S6 segments (27, 28). 
 
 
 
Figure 9. R83H, but not D90N, alters function of MiRP2/HERG complexes. Channels formed with HERG (triangle), wild-
type-MiRP2/HERG (filled square), R83H-MiRP2/HERG (open square), or D90N-MiRP2/HERG (gray square) in oocytes 
studied by two-electrode voltage clamp. A) Currents with varied prepulse voltage and a -30 mV tail (protocol 7, inset). Bath 
solution was 4 mM potassium solution. Scale bars represent 1 µA and1 s. B) Current-voltage relationships for cells as in 
panel A (arrow); mean ± SE for 18 – 40 oocytes. Curves fit to a function of the form: 1/{1+exp[(V1/2-V)/Vs]}, where V1/2 is 
the half-maximal voltage of activation and Vs the slope factor. 
 
 
Promiscuous interactions: a role in disease? 
 
We hypothesize here that interaction of MiRPs with a variety of α subunits and the capacity of MiRP 
mutations to alter function in the different complexes contribute to the varied clinical manifestations of 
MiRP-associated disease. Although the idea is appealing in its simplicity, proof for the hypothesis remains 
scant. A multiplicity of MIRP/α subunit interactions has been suggested by studies of cloned subunits in 
experimental cells, but in only a few cases has a direct comparison of cloned and native currents, transcript 
and/or protein expression, and/or linkage to human disease provided strong support for native assembly; 
these include MinK with KCNQ1 in heart and inner ear, MiRP1 with HERG in the heart, and MiRP2 with 
Kv3.4 in skeletal muscle (5– 8, 29, 30). 
Indeed, there is no compelling need to invoke promiscuous interactions in described KCNE-
associated disorders. Cardiac arrhythmia and deafness in association with MinK mutations can be fully 
rationalized by diminished function of MinK/KCNQ1 channels in both the heart and ear (29, 31–33). MiRP1 
mutations associated with a prolonged QT interval at baseline (Q9E, M54T, I57T, and A116V) act as one 
might expect to reduce currents passed through channels formed with HERG (by decreasing unitary 
conductance, shifting the voltage dependence of activation, and/or speeding of deactivation, thereby slowing 
cardiac repolarization) (7, 13). These rare mutations create a substrate for a poor response to further current 
suppression by drugs known to block cardiac potassium channels (13). More specific effects are observed 
with one rare mutation (Q9E) and a common polymorphism (T8A) linked to antibiotic-induced arrhythmia, 
as these MiRP1 variants increase sensitivity of MiRP1/ HERG channels to blockade by the inciting drugs (7, 
13). Finally, R83H-MiRP2 is associated with periodic paralysis and alters both the attributes of a prominent 
skeletal muscle cell potassium current and the resting membrane potential of muscle cells via endogenous 
MiRP2/Kv3.4 channels (8). 
Other observations remain controversial. We reported association of MiRP1 mutations with cardiac 
arrhythmias (inherited and drug-induced) and altered function of MiRP1/HERG channels (7, 13); others 
have subsequently suggested that MiRP1 interaction with KCNQ1 (34), HCN1 (18), or Kv4.2 (17) might 
instead produce abnormal cardiac rhythms. So far we have been unable to demonstrate an effect of MiRP1 
on KCNQ1 or HCN1 currents in either oocytes or CHO cells; evidence for these interactions may require 
 specific experimental conditions. We do observe MiRP1 to alter Kv4.2 subunit function (16), but suspect 
that this influences the central nervous system in humans rather than the heart as Kv4.2 transcript is 
abundant in the brain but appears to be absent from human heart (35). Similarly, patients with periodic 
paralysis in association with MiRP2 mutation show abnormal skeletal muscle cell function reflective of 
altered MiRP2/Kv3.4 channel activity (8); others speculate that the primary role for MiRP2 is with KCNQ1 
in the colon (based on transcript expression patterns) (20). Although notable effects of MiRP2 on KCNQ1 
are reproduced here, individuals with MiRP2-associated periodic paralysis did not show abnormal 
gastrointestinal function (8) as might be expected if MiRP2/KCNQ1 complexes were central to fluid 
handling in the colon (20). Moreover, two probes used to demonstrate abundant transcript for MiRP2 in 
human skeletal muscle failed to visualize mRNA in the colon (8). Finally, we could not recapitulate MiRP2 
suppression of KCNQ4 currents (20) when the two subunits were coexpressed in oocytes (not shown). 
Why, then, hypothesize a role for promiscuous interaction? First, there is marked variation among 
recognized cases of KCNE-associated disease in clinical presentation, response to medical intervention, and 
long-term outcome, which may reflect such additional MinK, MiRP1, or MiRP2 interactions. Second, 
function of KCNE peptides with multiple α subunit types might be difficult to discern if assembly takes 
place only in some cell types or under unique circumstances; indeed, cardiac potassium channel α subunits 
show spatial and temporal variation in expression during development and in disease (36). Finally, it is the 
very capacity of KCNE peptides to operate with different α subunits in experimental cells that impels 
consideration of the hypothesis that the interactions occur in nature. Proof requires discovery of a KCNE 
mutation that yields pathology due to its aberrant function in more than one channel type.   
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